Nonmelanoma Skin Cancer

Intralesional immunotherapy shows potential as a treatment for cutaneous malignancies, including nonmelanoma skin cancer, according to a speaker at this year’s ODAC Dermatology, Aesthetic & Surgical Conference.

Almirall has partnered with etherna for the development of mRNA-based therapies for the treatment of severe skin diseases, including nonmelanoma skin cancer, the companies announced in a press release.

A higher proportion of patients are dying from nonmelanoma skin cancer globally than melanoma, according to a press release from the European Academy of Dermatology and Venerology.

Fractional lasers may be a promising new treatment option for the prevention of nonmelanoma skin cancer by promoting skin regeneration and stopping photocarcinogenesis, according to a study.

Almirall and the Centre for Genomic Regulation have entered into a research collaboration to develop and characterize novel preclinical models for the identification of new nonmelanoma skin cancer treatments, according to a press release.

In honor of Skin Cancer Awareness Month, Healio has compiled the top skin cancer stories published so far in 2023.

Psoriasis patients taking methotrexate are nearly three times as likely to develop nonmelanoma skin cancer compared with those not taking the drug, according to a study.

Solid organ transplantation, age and a history of cancer were significant host risk factors for multiple and subsequent cutaneous squamous cell carcinoma, according to a large chart review.

NEW ORLEANS — Having proven a low recurrence rate, two treatments of the 595 nm pulsed dye laser may be a viable therapy for nonmelanoma skin cancer on the hands of older adult patients, according to a poster presented here.

The FDA announced several regulatory actions the past few weeks.